Privi Speci. (PRIVISCL)

FairStock Score: 48/100 — MIXED

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Return on equity of 32.37% shows strong capital efficiency.
• Sales growth of 23.18% and profit growth of 75.50% reflect robust recent momentum.
• Piotroski F-Score of 7/9 and promoter holding of 60.60% indicate financial soundness and aligned ownership.
• PEG of 0.80 suggests earnings growth could support valuation if sustained.

Concerns

• Free cash flow is negative at ₹-13 Cr despite ₹75 Cr quarterly profit, raising earnings-quality doubts.
• P/E of 39.53 and P/B of 12.65 leave no margin of safety versus book value of ₹257.06.
• D/E of 0.86 and ROCE of 16.42% mean leverage is boosting ROE; underlying operating returns are lower.
• 5-year revenue CAGR of 10.47% versus current 23.18% suggests possible cyclical acceleration.

AI Analysis

Let me look at Privi Speci through Benjamin Graham's eyes. At ₹3,250.80, I am asked to pay 39.53 times earnings and 12.65 times book value. Book value is only ₹257.06. That is not a margin of safety. The business does have qualities: return on equity is 32.37%, and latest profit growth of 75.50% with sales growth of 23.18% shows momentum. But I must ask whether it is durable. ROCE is 16.42%, so much of the high ROE comes from leverage; debt to equity is 0.86, not alarming but hardly fortress-like. More concerning, free cash flow is negative at ₹-13 Cr. A company reporting ₹75 Cr quarterly net profit should not burn cash. This makes me question earnings quality. The five-year revenue CAGR is only 10.47%, far below the latest 23.18% sales rise. That gap tells me the current growth may be cyclical rather than structural. Specialty chemicals can be a good business, but at this price the market expects perfection. The PEG ratio of 0.80 is tempting, but it assumes today's high profit growth continues, and growth on a base of ₹11,874 Cr becomes harder. Promoter holding of 60.60% is a plus; Piotroski F-score of 7 also suggests a financially sound firm. Still, a dividend yield of 0.16% gives me little while I wait. I'd call it a fast grower, but not a bargain. For a value investor, the price must offer enough upside to compensate for the risk of a cyclical slowdown. I would wait for a lower price or clear evidence that cash generation catches up with reported earnings.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer